BPC-157
Symbol Bp · MW 1420 Da
Pentadecapeptide from human gastric juice studied for tissue repair and gut protection. Oral capsules are the most common consumer form.
- Discovered
- 1993
- Half-life
- 15 minutes
- Approval
- Not FDA-approved
Quick facts
- Category
- Recovery
- Route
- Oral
- Molecular weight
- 1420 Da
- Half-life
- 15 minutes
- Discovered
- 1993
- Approval status
- Not FDA-approved
Reported effects
- Tendon & ligament repair
- Protects gut lining
- Vascular healing
Overview
BPC-157 is a popular recovery peptide commonly associated with tissue repair, gut health, tendon recovery, ligament support, and inflammation control. It is derived from a protective protein sequence found in the stomach, which is why it is often discussed for both digestive support and injury recovery. BPC-157 is frequently marketed as a peptide for muscle recovery, soft-tissue repair, joint support, and gastrointestinal protection. Much of the strongest evidence comes from animal and laboratory research, so its human benefits should be discussed carefully. Its main purpose is to support the body's natural repair processes, especially in areas involving tendons, ligaments, muscles, and the gut.
Evidence context
BPC-157 evidence summary
Human clinical evidence
BPC-157 has an approval context listed in the Peptidic database. Approved use still depends on the specific indication, formulation, labeling, and clinician guidance.
Animal, preclinical, or formulation evidence
BPC-157 may be discussed in animal, preclinical, in vitro, or early-stage research contexts. Those evidence types are useful for orientation but should not be treated as equivalent to approved human indications.
Status and evidence strength
Peptidic lists the approval status for BPC-157 as Not FDA-approved. The reported effects below are reference fields from the peptide database, not medical promises. Source links are included later on the page when available so readers can continue review from primary or reputable sources.
How it's taken
- Typical Administration
- Injectable / Oral
- Typical Dosage
- No established approved dosage; commonly referenced range is 200–500 mcg daily
- Typical Frequency
- Once or twice daily
Dosing depends on the approved indication, formulation, titration schedule, and clinician guidance. This page is educational and not a substitute for medical advice.
Research sources
Source links included from peer-reviewed literature, clinical records, and medical databases for educational research context on BPC-157.
Internal links
Related peptides
Frequently asked questions
What category is BPC-157 in?
BPC-157 is listed in the Recovery category on Peptidic.
What route is BPC-157 associated with?
BPC-157 is associated with the oral route in the Peptidic database. This is descriptive route context, not a use instruction.
Is BPC-157 approved?
Peptidic lists the approval status for BPC-157 as: Not FDA-approved. Approval details can vary by indication and jurisdiction.
Interested in BPC-157?
Enter your email and we'll send our recommended peptide vendor for educational research reference.
Review the peptide vendor research checklistEducational reference only · No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions. Explore the full peptide database, peptide calculator, or peptide tracker.
Last reviewed for educational accuracy: 2026-06-01